Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Bhupat D. Rawal"'
Autor:
Bhupat D. Rawal, Anne-Marié Pretorius
Publikováno v:
Medical Hypotheses. 65:1062-1066
Morphological, cultural, and immuno-histochemical characteristics of "Nanobacterium sanguineum" (NB) described in the literature are reviewed. NB is reported to be a motile, Gram negative organism that divides by binary fission within a calcium-coate
Autor:
Bhupat D. Rawal, Steven Kleinman, Anne L. McNamara, Simone A. Glynn, Michael P. Busch, Mary C. Kuhns
Publikováno v:
Transfusion. 44:1332-1339
BACKGROUND: Studies showing a significant correlation between hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) deoxyribonucleic acid (DNA) levels have focused on the HBV seroconversion window period. STUDY DESIGN AND METHODS: HBsAg lev
Autor:
David J. Wright, Richard T. Schumacher, Richard Smith, Charles M. Heldebrant, Patricia E. Garrett, Steven Kleinman, Peddada Lorraine B, Eberhard W. Fiebig, Andrew Conrad, Michael P. Busch, Bhupat D. Rawal
Publikováno v:
AIDS. 17:1871-1879
Objectives The characterization of primary HIV infection by the analysis of serial plasma samples from newly infected persons using multiple standard viral assays. Design A retrospective study involving two sets of archived samples from HIV-infected
Autor:
Bhupat D. Rawal, Azucena Degula, Frederick Hecht, Haynes W. Sheppard, Ludmila Lebedeva, Michael P. Busch, Robert S. Janssen
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 33:349-355
The sensitive/less-sensitive (S/LS) enzyme immunoassay (EIA) testing strategy for discriminating "early" from "longstanding" HIV infection has been widely applied for detecting recent seroconverters and estimating HIV incidence rates. The originally
Autor:
Bhupat D. Rawal, Peter Bacchetti, Jennifer Lorvick, Alex H. Kral, Michael P. Busch, Brian R. Edlin, Lauren Gee
Publikováno v:
American Journal of Epidemiology. 157:915-922
This paper reports trends in human immunodeficiency virus (HIV) incidence among street-recruited injection drug users (IDUs) in San Francisco, California, from 1987 through 1998, estimated using a sensitive/less sensitive enzyme immunoassay testing s
Autor:
Maria Cecília Araripe Sucupira, Bhupat D. Rawal, Michael P. Busch, Ricardo Sobhie Diaz, Maria Elvira Falcao, George W. Rutherford, Katia Alves, Marcos Montani Caseiro, Kimberly Page Shafer
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 32:551-559
Objectives: To determine temporal trends in HIV infection and risk factors among persons seeking anonymous HIV testing in Santos Brazil. Methods: Data and sera from persons testing for HIV from 1996 to 1999 were used. Exposures were abstracted from H
Autor:
Hillard Weinstock, Monica Dale, Marta Gwinn, Glen A. Satten, Denise Kothe, Joanne Mei, Janet Royalty, Laurie Linley, Carol Fridlund, Bharat Parekh, Bhupat D. Rawal, Michael P. Busch, Robert S. Janssen
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 29:478-483
Although the numbers of newly reported diagnoses of AIDS decreased in the 1990s, it is not clear whether they reflect a decreasing number of new HIV infections. Direct measurement of HIV incidence through follow-up cohort studies is difficult and cos
Publikováno v:
Biologicals. 23:75-81
In vitro inactivation of cell-free human immunodeficiency virus (CFHIV) was investigated by mixing replication-competent virions with aliquots of a culture medium (RPMI) containing increasing amounts (62.5-500 micrograms/ml) of ascorbic acid (AA) at
Autor:
J M Romeo, Bhupat D. Rawal, Paul P. Ulrich, Girish N. Vyas, G Yang, T M Sankary, Michael P. Busch
Publikováno v:
Transfusion. 34:656-660
Background: Since screening for antibody to hepatitis C virus (HCV) was introduced in 1990, posttransfusion hepatitis has been reduced to nearly background levels. This has led to reconsideration of the value of testing donated blood for elevated ala
Publikováno v:
Blood. 81:1083-1088
Blood donations are routinely screened by multiple serologic assays for antigens/antibodies associated with infection by blood-borne viruses, including hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency viruses (HIV-1 and HIV-2)